O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189896 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Itzel Patricia Vásquez Martínez und 9 weiteren Autor:innen. Beteiligte Einrichtung: UNAM-UABJO Faculty of Medicine Research Center, Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca 68020, Mexic…. Hauptthemen laut MEDLINE: Neoplasms, Inflammation, Hemostasis, Acetylglucosamine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
O-linked β-N-acetylglucosamine (O-GlcNAc, O-GlcNAcylation) is a post-translational modification of serine/threonine residues of proteins. Alterations in O-GlcNAcylation have been implicated in several types of cancer, regulation of tumor progression, inflammation, and thrombosis through its interaction with signaling pathways. We aim to explore the relationship between O-GlcNAcylation and hemostasis, inflammation, and cancer, which could serve as potential prognostic tools or clinical predictions for cancer patients’ healthcare and as an approach to combat cancer. We found that cancer is characterized by high glucose demand and consumption, a chronic inflammatory state, a state of hypercoagulability, and platelet hyperaggregability that favors thrombosis; the latter is a major cause of death in these patients. Furthermore, we review transcription factors and pathways associated with O-GlcNAcylation, thrombosis, inflammation, and cancer, such as the PI3K/Akt/c-Myc pathway, the nuclear factor kappa B pathway, and the PI3K/AKT/mTOR pathway. We also review infectious agents associated with cancer and chronic inflammation and potential inhibitors of cancer cell development. We conclude that it is necessary to approach both the diagnosis and treatment of cancer as a network in which multiple signaling pathways are integrated, and to search for a combination of potential drugs that regulate this signaling network.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UNAM-UABJO Faculty of Medicine Research Center, Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca 68020, Mexico.
- National Institute of Technology of Mexico, Technological Institute of Oaxaca, Oaxaca 68033, Mexico.
- Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
- National Council of Humanities, Sciences and Technologies (CONAHCYT), Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca 68120, Mexico.
ORCID-Profile: Itzel Patricia Vásquez Martínez, Eduardo Pérez-Campos, Laura Pérez-Campos Mayoral, Holanda Isabel Cruz Luis, Edgar Zenteno, Irma Leticia Bazán Salinas, María Teresa Hernández-Huerta
Zitieren
APA
Vásquez Martínez, I. P., Pérez-Campos, E., Pérez-Campos Mayoral, L., Cruz Luis, H. I., Pina Canseco, M. D. S., Zenteno, E., Bazán Salinas, I. L., Martínez Cruz, M., Pérez-Campos Mayoral, E., & Hernández-Huerta, M. T. (2024). O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189896
Vancouver
Vásquez Martínez IP, Pérez-Campos E, Pérez-Campos Mayoral L, Cruz Luis HI, Pina Canseco MDS, Zenteno E, et al. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189896
BibTeX
@article{VsquezMartnez2024,
author = {Vásquez Martínez, Itzel Patricia and Pérez-Campos, Eduardo and Pérez-Campos Mayoral, Laura and Cruz Luis, Holanda Isabel and Pina Canseco, María Del Socorro and Zenteno, Edgar and Bazán Salinas, Irma Leticia and Martínez Cruz, Margarito and Pérez-Campos Mayoral, Eduardo and Hernández-Huerta, María Teresa},
title = {O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189896}
}
EUVIMED